How to Prove Microplastic Reduction: A Verified Approach

Key Takeaways

• Proving microplastic reduction requires a documented baseline, a controlled intervention, a qualified analytical method, statistical comparison, and independent review against a published standard.
• Without all three elements, including a documented baseline, a controlled intervention with statistical comparison, and independent review, a lab report cannot support a defensible public claim.
• The analytical method must fit the product type and particle-size range, and the laboratory’s capability must be confirmed before testing so results can support verification.
• Independent review under WQI-CS-01 converts laboratory datasets into verified claims with approved language, public registry listing, and defined scope limits.
• Companies with existing lab data on microplastic levels can learn how The Wellness Quality Institute can help turn that data into verified claims.

What Proof of Microplastic Reduction Requires

Proving microplastic reduction is a structured process, not a single test result. Detection shows that microplastics are present, while reduction requires a before-and-after comparison under controlled conditions, using a qualified analytical method, with results reviewed independently against defined criteria. A single clean result cannot demonstrate reduction on its own. The five steps below walk through the full sequence from baseline sampling through independent review.

Step 1: Establish a Baseline Sampling Protocol You Can Defend

A baseline is the documented starting point against which any reduction is measured. Without it, there is nothing to compare later results to. A defensible baseline depends on clear decisions about sampling design, container materials, contamination controls, and documentation before the first sample is collected.

Water samples for microplastics analysis are typically collected in pre-cleaned glass containers, with holding times, shipment, and storage conditions following laboratory protocols to prevent degradation or contamination during transit. Because any variation between baseline and post-intervention sampling can blur the results, the sampling location, depth, flow conditions, and collection method must all be recorded and kept constant across both sampling runs.

Contamination control is not optional at this stage, because every later result rests on it. Field blanks detect contamination introduced during sampling, procedural blanks identify laboratory contamination, and air blanks monitor airborne fibers. All three types should run alongside every sampling batch. Laboratories should prohibit synthetic-fiber clothing and cosmetics during collection and handling, and should rely only on glass and metal containers and instruments.

The scope boundaries established at baseline define the scope of any future claim. The tested particle-size range, the polymer panel screened, the product matrix, and the production or sampling period are all fixed at this step, establishing the maximum reach of any claim derived from the data.

Step 2: Design a Controlled Intervention That Is Clearly Documented

A controlled intervention is the specific change in packaging, filtration, sourcing, or process that the study will evaluate for its effect on microplastic levels. The intervention must be defined precisely before post-intervention sampling begins. The post-intervention sampling protocol then needs to mirror the baseline protocol in every material respect, including locations, container types, contamination controls, and analytical method.

A control group or control condition, meaning a parallel sample set that does not receive the intervention, provides the clearest way to separate the intervention’s effect from background variability, seasonal changes, or other confounding factors. In a one-group pre-post design without a control group, changes cannot be attributed solely to the intervention because alternative explanations such as maturation, testing effects, or history cannot be ruled out. When a matched control group is not feasible, the study design and its limitations should be documented explicitly.

The intervention record should state what changed, when it changed, and what remained constant. Lot-to-lot variability in production means that a result from one production run does not automatically represent the next. Multiple sampling events across the post-intervention period create a much stronger dataset.

Step 3: Select and Qualify the Analytical Method for Your Product

The analytical method sets the boundaries for what the data can and cannot show. Three primary techniques are used for microplastics in water: micro-FTIR spectroscopy (µFTIR), micro-Raman spectroscopy (µRaman), and pyrolysis gas chromatography-mass spectrometry (Py-GC/MS). Each technique covers a different particle-size range and has different strengths and limitations.

µFTIR covers particle sizes from approximately 10 µm to 5,000 µm and is suited for routine analysis of clean water, while µRaman is suited for smaller microplastics, typically down to about 1 µm and often preferred below 50 µm. Py-GC/MS provides information about total polymer mass but no particle size, shape, or number. The method must match both the product matrix and the particle-size range that the study intends to address.

To show how published methods define these parameters in practice, one state’s drinking-water microplastics framework provides two analytical methods that serve as a credible public reference point for method selection. SWB-MP1-rev1 uses infrared spectroscopy and is validated for particles greater than 50 µm through 5,000 µm. SWB-MP2-rev1 uses Raman spectroscopy and is validated for particles greater than 20 µm through 5,000 µm. The 1–20 µm fraction is not validated under either method. ISO 16094-2:2025 provides an additional reference for vibrational spectroscopy in clean water matrices including drinking water, though it is not automatically interchangeable with those methods. Method, matrix, and laboratory validation all require separate review.

The detection floor, meaning the smallest particle size the method can reliably identify, must be stated explicitly in any claim derived from the data, because this floor defines what “none detected” actually means. A result of “none detected” means none found above that floor, for the polymers screened, in the lot tested, not none present at any size or in any form.

The laboratory performing the analysis must also be independently qualified. The Wellness Quality Institute’s review standard, WQI-CS-01, recognizes three laboratory tiers: laboratories accredited for the applicable method (preferred), ISO/IEC 17025-accredited laboratories with the method and matrix explicitly within accredited scope (accepted), and other qualified independent laboratories subject to documented method-equivalence review (conditional). Confirming laboratory qualification before commissioning testing prevents the costly outcome of paying for data that cannot support a verification review.

Step 4: Compare Results Statistically and Account for Blanks and Controls

Raw numbers from pre- and post-intervention sampling do not, by themselves, establish a reduction claim. Statistical analysis is required to determine whether an observed difference is meaningful or falls within normal measurement variability.

The appropriate statistical test depends on the study design. For a simple one-group pre-post design, a paired samples t-test accounts for the linkage between each unit’s pre- and post-intervention observations, while for two-group designs including a treatment and control group, ANCOVA is often preferred because it provides greater statistical power and controls for pre-existing differences. When data are not normally distributed or sample sizes are small, nonparametric alternatives such as the Wilcoxon signed-rank test are appropriate. In one pilot study of microplastic reduction, the Wilcoxon signed-rank test was applied as the primary inferential method, with a matched control group showing no significant change, demonstrating that the paired design accounts for temporal variability.

Blank data must be reported alongside sample data so contamination can be separated from true sample content. Confidence intervals should accompany particle counts and mass estimates, with sampling uncertainty explicitly accounting for spatial and temporal variability and recovery efficiency. Results should appear as both raw and blank-corrected figures, including the mean and standard deviation of blank particles.

This blank-correction requirement becomes particularly critical when post-intervention samples return no detectable particles, because that scenario raises a specific reporting challenge. Concentrations below the method limit of quantification are typically assigned the mean value between the method limit of detection and the limit of quantification, and concentrations below the limit of detection are assigned one-half the detection limit value. These assignment conventions underscore that a “none detected” result is not a zero. It is a bounded statement whose evidentiary weight depends entirely on whether the reporting limit meets defined requirements. Without an adequate reporting limit, as discussed in Step 3, the non-detect result proves nothing.

Counts must be reported by size fraction rather than as a single aggregate figure. Visual identification alone is never sufficient, because particles must be chemically confirmed by spectroscopy. Visual and fluorescent methods enable particle counting but provide no chemical verification of polymer type, while spectroscopic techniques confirm polymer identity but are typically limited to particles larger than 1–10 µm.

Step 5: Submit the Dataset for Independent Review Against WQI-CS-01

Independent review is the step that converts a laboratory dataset into a defensible market claim. Self-reported results, even when based on rigorous testing, are read by retailers, procurement teams, and consumers as marketing, because the company grading its own homework has a clear interest in the outcome. An independent third party with no commercial stake in the result, reviewing data against published criteria, produces a finding that self-reporting structurally cannot.

The Wellness Quality Institute’s review standard, WQI-CS-01, assesses the full dataset against defined requirements. The review examines laboratory accreditation tier, analytical method and matrix suitability, tested particle-size range, target polymer panel, reporting limits, blank and contamination controls, replication, chain of custody, data recency, and product scope. The minimum target polymer panel under WQI-CS-01 includes eight common polymers, including PE, PP, PET, PS, PVC, PA, PC, and PMMA, plus required reporting categories for other confirmed polymers and for unidentified particles with no spectral match.

Once the review assesses the dataset against all these requirements, it produces one of two outcomes. Standard Met requires that the dataset satisfies all applicable technical and data-quality requirements and that no reportable target polymer particles are detected within the tested particle-size range and approved reporting limits. A non-detect result alone is not enough if the reporting limits do not meet WQI requirements. Standard Not Met is issued where one or more requirements are unsatisfied and is a private outcome that is never described as a failed product. It may reflect insufficient data, an unsupported method, or incomplete scope rather than anything about the product itself, and the company may resubmit with corrected or additional information.

A Standard Met outcome carries a verification decision with registry listing, a registry ID, and approved claim language tied to the specific reviewed evidence. Verification applies only to the reviewed product, dataset, tested particle-size range, polymer panel, and production period. No company-wide or product-line claim may be extended from a single dataset.

Turn Real Lab Data into a Claim You Can Stand Behind

If your company holds independent laboratory data on microplastic levels and needs to know what that data can defensibly support, The Wellness Quality Institute reviews existing datasets against WQI-CS-01 and produces a verified outcome tied to the reviewed evidence. Talk to WQI about Plastic-Free Pathway Verification and find out what your data can actually prove.

Verification Checklist: What WQI-CS-01 Reviews

Review Element	What It Covers	Why It Matters
Laboratory accreditation tier	Laboratories accredited for the applicable method (preferred), ISO/IEC 17025 with method and matrix in scope (accepted), or conditional with equivalence review	Unaccredited laboratory data cannot support a verified claim regardless of the result
Analytical method and matrix suitability	Method must be appropriate for the specific product matrix, such as drinking water or functional beverages, using published methods or reviewed equivalents	A method valid for one matrix may be unsuitable for another, and a method-matrix mismatch invalidates results
Tested particle-size range	Must be stated explicitly, with infrared validated above 50 µm and Raman above 20 µm, both to 5,000 µm, and the 1–20 µm fraction not validated under either published method	Claims cannot extend below the method’s detection floor, because the size range defines the scope of any result
Target polymer panel	Minimum: PE, PP, PET, PS, PVC, PA, PC, PMMA, plus reporting categories for other confirmed polymers and unidentified particles	A panel that omits common polymers leaves gaps that undermine the claim
Reporting limits	Must meet WQI requirements, because a non-detect result paired with an inadequate reporting limit carries no evidentiary weight	The reporting limit defines what “none detected” actually means
Blank and contamination controls	Field blanks, procedural blanks, and air blanks, with results reported as raw and blank-corrected data including mean and standard deviation	Without blank data, contamination cannot be distinguished from sample content
Replication	Multiple samples, counts reported by size fraction, and chemical confirmation of all counted particles	Single-sample results cannot account for lot-to-lot variability
Chain of custody	Documented sample collection, handling, transfer, and storage from field to laboratory	An unbroken chain of custody is required for results to be attributable to the sampled product
Data recency	Verification period of 24 months from the sampling date of the most recent accepted dataset	Older data does not represent current production, so re-verification uses current data
Product scope	Specific product, SKU, matrix, and production or sampling period, with no extension to product lines or company-wide claims	Scope lock prevents a single dataset from being stretched into a claim it cannot support

These ten review elements work together as a system, so a dataset that satisfies nine requirements but fails one cannot support a verified claim. The scope lock in the final row, limiting verification to the specific product, dataset, size range, polymer panel, and production period reviewed, prevents a single clean result from being stretched into a claim it cannot support.

WQI Plastic-Free Pathway Verification does not certify that a product contains zero plastic, microplastics, or nanoplastics. It shows that the company is on a verified pathway toward plastic-free standards. Verification applies only to the reviewed products, submitted datasets, tested ranges, polymer panels, production or sampling periods, and supporting controls. WQI verification is not a government approval, government certification, or health or safety certification.

Frequently Asked Questions

What does “none detected” on a lab report actually mean?

“None detected” means no particles were found above the instrument’s detection floor, for the specific polymers the method screened, in the lot that was tested. It is a bounded statement, not a guarantee of absence. A method that begins at 50 micrometers, about half the width of a human hair, cannot see anything smaller, so particles below that threshold fall outside the method’s reach. The reporting limit matters as much as the result, because a non-detect result paired with an inadequate reporting limit carries no evidentiary weight under WQI-CS-01. Knowing exactly what “none detected” covers is one of the most common and consequential gaps that The Wellness Quality Institute’s review process addresses for companies holding existing lab data.

Can a company use its existing lab data, or does it need to commission new testing?

The Wellness Quality Institute reviews existing independent laboratory datasets, so companies do not need to commission new testing solely to start a review. The review assesses whether the existing data meets WQI-CS-01 requirements across laboratory accreditation, analytical method, matrix suitability, particle-size range, polymer panel, reporting limits, blank controls, replication, chain of custody, and data recency. When the existing dataset is incomplete, uses an unsupported method, or was produced by a laboratory that does not qualify under WQI’s accreditation tiers, the review identifies those gaps specifically. Many companies discover that their existing data supports a narrower or a stronger claim than they assumed before independent review. A single assessment fee covers the review, verification decision, and registry listing, while independent laboratory testing, if new testing is needed, is arranged and billed separately by a qualified independent laboratory.

What is the difference between a verification and a certification?

A certification implies a settled, guaranteed state, meaning that a product has been confirmed to meet a fixed standard in an absolute sense. The Wellness Quality Institute deliberately does not use “certified” or “certification” for its program, because no such guarantee is scientifically available for microplastic content. No laboratory today can confirm the complete absence of plastic across every particle size, polymer type, and production lot. A verification describes what actually happened, which is an independent review of a specific dataset against defined criteria, producing a scope-locked outcome tied to the reviewed product, method, size range, polymer panel, and production period. The distinction affects real-world claims, because it separates what the science can support from what it cannot.

What happens if a dataset does not meet the standard?

A Standard Not Met outcome is private. It carries no public claim, no logo rights, and no registry listing. It is never described as a failed product, because it frequently reflects the testing rather than the product, such as an unsupported analytical method, inadequate reporting limits, missing blank data, incomplete polymer analysis, or a laboratory that does not qualify under WQI’s accreditation tiers. The company may submit corrected or additional information for future review. Participating in the review process creates no public downside risk, by design, so a brand that submits data and receives a Standard Not Met outcome remains in exactly the same public position it held before submitting.

Does WQI verification apply to an entire product line or company?

No. Verification under WQI-CS-01 is scope-locked to the specific dataset reviewed, as described in Step 5. This means a single clean result for one product and production period cannot be extended to an entire product line or used as a company-wide claim. Every Standard Met product receives its own public registry entry recording the exact scope of what was reviewed, and every public claim must link to that registry ID. This scope lock is the mechanism that prevents a single clean result from being stretched into a claim it cannot support, which is how credible data can otherwise turn into greenwashing.

Conclusion

Proving microplastic reduction requires more than a laboratory report. It requires a documented baseline, a controlled intervention, a qualified analytical method with stated detection limits, statistical comparison with blanks and controls, and independent review against a published standard. Each step builds on the last, and the absence of any one of them leaves the claim without a foundation it can stand on.

The gap between holding real laboratory data and making a defensible public claim is not a gap in effort, because most companies that commission independent testing are acting in good faith. It is a gap in process, because without the sequential, documented, independently reviewed pathway that converts raw results into a scope-locked, registry-backed finding, even rigorous lab data remains self-reported marketing. WQI-CS-01 defines that pathway, and Plastic-Free Pathway Verification executes it.

In a market where unverifiable plastic claims are becoming a legal and reputational liability, the defensible claim is the more valuable one. Turn real lab data into a claim you can support and talk to The Wellness Quality Institute about Plastic-Free Pathway Verification.